Why Invest in MassBio Innovation Services for Access to Cutting Edge Life Science Opportunities

Why you need to invest in MassBio Innovation Services!

Despite yearly increases in R&D spending, approvals stagnate 10 20 30 40 50 60 40 30 20 10 1995 2000 2005 50 NMEs and Biologics Approved R&D Spending (US$ Billions) R&D expenditures Approvals Sources: FDA/CDER, PhRMA, PricewaterhouseCoopers Note: R&D spending from non-PhRMA companies not available Courtesy of Ted Torphy, JNJ presented at MassBio Pharma Days

Pharma’s failure to innovate means biotech innovation must step up ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Life sciences innovation is the lifeblood of biopharmaceuticals ,[object Object],[object Object],[object Object],Established “Specialty Clusters” Cluster Size Large Emerging Cluster Capability Small World-class SF MA SD Singapore India China United Kingdom Ireland Switzerland Philadelphia RTP Canada Madison DC / Baltimore Integrated Clusters Emerging Clusters Leading Integrated Clusters Lagging Integrated Clusters

New partnerships are needed among key stakeholders to drive innovation ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

The fount of opportunity for pipeline growth and enabling technology exists with new start-ups ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

MassBio programs connect talent, innovation, and capital through its network . ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

MassCONNECT – advise, mentor, and steer emerging companies arising from the program. ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

MassBio Innovation Exchange – Access and maximize opportunity assessment for world class IP and leading biotechnology companies ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Pharma Days – Concentrated and focused partnering with premiere biotech companies at your convenience ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Best of all, Pharma Days is right here in Cambridge! No need to travel, take time out of your offices, or waste time trying to find a time to meet. ,[object Object],[object Object],[object Object],[object Object],[object Object]

MassBio Investors Forum – Aggregates deal makers from all sides at one location ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Innovators Roundtables – Solutions-based dialogue with leaders in industry and stakeholders ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Subscribe to MBIS services ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Why Invest in MassBio Innovation Services for Access to Cutting Edge Life Science Opportunities

Recommended

Recommended

More Related Content

Viewers also liked

Viewers also liked (7)

Similar to Why Invest in MassBio Innovation Services for Access to Cutting Edge Life Science Opportunities

Similar to Why Invest in MassBio Innovation Services for Access to Cutting Edge Life Science Opportunities (20)

Recently uploaded

Recently uploaded (20)

Why Invest in MassBio Innovation Services for Access to Cutting Edge Life Science Opportunities

Editor's Notes